Τόμος 28 (2010) – Τεύχος 2 – Άρθρο 7 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 28 (2010) – Issue 2 – Article 7 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Ευστράτιος Μωραλίδης¹, Κωνσταντίνος Καρακατσάνης²

¹Λέκτορας, Β΄ Εργαστήριο Πυρηνικής Ιατρικής, ΑΧΕΠΑ, ²Καθηγητής Δ/ντής, Α΄ Εργαστήριο Πυρηνικής Ιατρικής, Ιπποκράτειο Νοσοκομείο, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

Efstratios Moralidis¹, Constantinos Karakatsanis²

¹2^nd Dept of Nuclear Medicine, Aristotle University Medical School, AHEPA Hospital, ²1^st Dept of Nuclear Medicine, Aristotle University Medical School, Hippokration Hospital, Thessaloniki, Hellas

2. Ansari M., Massie B.M.: Heart failure: how big is the problem? Who are the patients? What does the future hold? Am. Heart J. 146: 1-4 (2003)

3. Klocke F.J., Baird M.G., Bateman T.M., et al.: ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardi-ology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). (2003). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/ guidelines/radio/rni_fulltext.pdf.

4. Hunt S.A., Abraham W.T., Chin M.H., et al.: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/failure//index.pdf.

5. The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology. Guidelines for the diagnosis and treatment of congestive heart failure (update 2005). Available at: http://www.escardio.org.

6. Bulkley B.H., Hutchins G.M., Bailey I., et al.: Thallium 201 imaging and gated cardiac blood pool scans in patients with ischemic and idiopathic congestive cardiomyopathy. Circulation 55: 753-60 (1997)

7. Saltissi S., Hockings B., Croft D.N., et al.: Thallium-201 myocardial imaging in patients with dilated and ischaemic cardiomyopathy. Br. Heart J. 46: 290-295 (1981)

8. Dunn R.F., Uren R.F., Sadick N., et al.: Comparison of thallium 201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Circulation 66: 804-810 (1982)

9. Eichhorn E.J., Kisinski E.J., Lewis S.M., et al.: Usefulness of dipyridamolethallium 201 perfusion scanning for distinguishing ischemic from nonischemic cardiomyopathy. Am. J. Cardiol. 62: 945-951 (1988)

10. Chikamori T., Doi Y.L., Yonezawa Y., et al.: Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am. J. Cardiol. 69: 650-653 (1992)

11. Tauberg S.G., Orie J.E., Bartlett B.E., et al.: Usefulness of thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy. Am. J. Cardiol. 71: 674-680 (1993)

12. Danias P.G., Ahlberg A.W., Clark B.A. III, et al.: Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am. J. Cardiol 82: 1253-1258 (1998)

13. Wu Y.-W., Yen R.-F., Chieng P.-U., et al.: Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. J. Nucl. Cardiol. 10: 369-374 (2003)

14. Yao S.-S., Qureshi E., Nichols K., et al.: Prospective validation of a quantitative method for differentiating ischemic versus nonischemic cardiomyopathy by technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. Clin. Cardiol. 27: 615–620 (2004)

15. Danias P.G., Papaioannou G.I., Ahlberg A.W., et al.: Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am. J. Cardiol. 94: 14-19 (2004)

16. Mody V.F., Brunken R.C., Stevenson W.L., et al.: Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. J. Am. Coll. Cardiol. 17: 373-383 (1991)

17. Boffa G.M., Zanco P., Valentina P.D., et al.: Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy. Int. J. Cardiol. 74: 67-74 (2000)

18. Pasternac A., Noble J., Streulens Y., et al.: Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 65: 778-789 (1982)

19. Cannon R.O,3rd, Cunnion R.E., Parrillo J.E., et al.: Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. J. Am. Coll. Cardiol. 10: 1190-1200 (1997)

20. Mahrholdt H., Zhydkov A., Hager S., et al.: Left ventricular wall motion abnormalities as well as reduced wall thickness can cause false positive results of routine SPECT perfusion imaging for detection of myocardial infarction. Eur. Heart J. 26: 2127-2135 (2005)

21. Hassan N., Escanyé J.-M., Juillère Y., et al.: 201Tl SPECT abnormalities, documented at rest in dilated cardiomyopathy, are related to a lower than normal myocardial thickness but not to an excess in myocardial wall stress. J. Nucl. Med. 43: 451-457 (2002)

22. Tian Y., Liu S., Shi R., et al.: Radionuclide techniques for evaluating dilated cardiomyopathy and ischemic cardiomyopathy. Chin. Med. J. 113: 392-395 (2000)

23. Eisenberg J.D., Sobel B.E., Geltman E.M.: Differentiation of ischemic from nonischemic cardiomyopathy with positron emission tomography. Am. J. Cardiol. 59: 1410-1414 (1987)

24. Greenberg J.M., Murphy J.H., Okada R.D., et al.: Value and limitations of radionuclide angiography in determining the cause of reduced left ventricular ejection fraction: comparison of idiopathic dilated cardiomyopathy and coronary artery disease. Am. J. Cardiol. 55: 541-544 (1985)

25. Iskandrian A.S., Hakki A.-H., Kane S.: Resting thallium-201 myocardial perfusion patterns in patients with severe left ventricular dysfunction: differences between patients with primary cardiomyopathy, chronic coronary artery disease, or acute myocardial infarction. Am. Heart J. 111: 760-767 (1986)

26. Iskandrian A.S., Helfeld H., Lemlek J., et al.: Differentiation between primary dilated cardiomyopathy and ischemic cardiomyopathy based on right ventricular performance. Am. Heart J. 123: 768-773 (1992)

27. La Vecchia L., Zanolla L., Varotto L., et al.: Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. Am. Heart J. 142: 181-189 (2001)

28. Diaz R.A., Nihoyannopoulos P., Athanassopoulos G.A., et al.: Usefulness of echocardiography to differentiate dilated cardiomyopathy from coronary-induced congestive heart failure. Am. J. Cardiol. 68: 1224-1227 (1991)

29. Alderman E.L., Fisher L.D., Litwin P., et al.: Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 68: 785-795 (1983)

30. Bounos E.P., Mark D.B., Pollock B.G., et al.: Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 78: I-151-7 (1988)

31. Udelson J.E., Shafer C.D., Carrio I.: Radionuclide imaging in heart failure: αssessing etiology and outcomes and implications for management. J. Nucl. Cardiol. 9: S40-S52 (2002)

32. Singh M., Rihal C.S., Lennon R.J., et al.: Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions. J. Am. Coll. Cardiol. 44: 357-361 (2004)

33. Kurtz C.E., Gerber Y., Weston S.A., et al.: Use of ejection fraction tests and coronary angiography in patients with heart failure. Mayo Clin. Proc. 81: 906-913 (2006)

34. Miller W.L., Hodge D.O., Tointon S.K., et al.: Relationship of myocardial perfusion imaging findings to outcome of patients with heart failure and suspected ischemic heart disease. Am. Heart J. 147: 714-720 (2004)

35. Doi Y.L., Chikamori T., Takata J., et al.: Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 67: 188-193 (1991)